Custom Antibody Market worth $652 million by 2026 - Exclusive Report by MarketsandMarkets™

CHICAGO, May 4, 2021 /PRNewswire/ -- According to the new market research report "Custom Antibody Market by Service (Antibody Development, Production, Labelling), Type (Monoclonal, Polyclonal, Recombinant), Source (Rabbit, Mice), Research Area (Oncology, Immunology), End User (Pharmaceutical Companies, CROs) - Global Forecast to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 652 million by 2026 from USD 393 million in 2021, at a CAGR of 10.6% during the forecast period.

Browse in-depth TOC on "Custom Antibody Market"

166 – Tables
29 – Figures
189 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=164328301

As such, an increase in research activity-especially in the life sciences industry-along with growing industry-academia collaborations are the primary growth drivers for this market. In addition, the objective behind custom antibody production is to acquire an antibody that performs well in a particular qualitative or quantitative immunodetection method. The quality of catalog antibodies (to ensure the reproducibility of results) is also an area of concern in this market, which is primarily why end users prefer custom-made antibodies.

Antibody Development accounted for the largest share of custom antibody market

Based on service, the market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. Antibody development services accounted for the largest market share of 56.6% in 2020. The large share of this segment can be attributed to the increasing focus of researchers on high-quality antibodies for reproducibility, which can be hampered by using commercially available antibodies.

Monoclonal antibody accounted for the largest share of custom antibody market

Based on type, the market is segmented into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other custom antibodies. The recombinant antibodies segment is projected to witness the highest growth rate during the forecast period. The increasing development of recombinant antibodies due to advantages such as batch-to-batch reproducibility and rapid production is propelling the growth of this market segment.

Pharmaceutical & biotechnology companies is the fastest-growing end user segment of the custom antibody market

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations. The pharmaceutical & biotechnology companies segment held the largest share of the custom antibody market in 2020. The large share of this segment is attributed to the increasing demand for high-specificity antibodies for drug discovery and development, increasing research in the areas of genomics and proteomics, and the need for antibodies in the identification of new targets and assays. Additionally, the impact of COVID-19 has encouraged various pharmaceutical companies to enter into collaborations with custom antibody service providers to develop COVID-19 antibodies.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=164328301

North America accounted for the largest share of the custom antibody market

North America accounted for the largest share of the custom antibody market, followed by Europe in 2019. The dominance of the North American region can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, increasing focus on developing antibody-based therapeutics, and the presence of a large number of global players in this region. On the other hand, the Asia Pacific market is estimated to witness the highest growth during the forecast period, primarily due to the increasing investments by governments and industries, growing biotechnology research, and rising awareness on personalized therapeutics.

Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=164328301

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023

https://www.marketsandmarkets.com/Market-Reports/neuroscience-antibodies-assays-market-129888612.html

Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blotting, Flow Cytometry), Application (Proteomics, Drug Development), End User - COVID-19 Impact - Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/research-antibodies-reagents-market-94212793.html

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets' flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected] 
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/custom-antibody-market.asp 
Visit Our Web Site: https://www.marketsandmarkets.com 
Content Source:  https://www.marketsandmarkets.com/PressReleases/custom-antibody.asp

SOURCE MarketsandMarkets